127 related articles for article (PubMed ID: 32798269)
1. Maintenance therapy of childhood acute lymphoblastic leukemia: Do all roads lead to Rome?
Schmiegelow K
Pediatr Blood Cancer; 2020 Nov; 67(11):e28418. PubMed ID: 32798269
[No Abstract] [Full Text] [Related]
2. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
[TBL] [Abstract][Full Text] [Related]
3. Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and Lymphoma during maintenance therapy.
Barone T; Dandekar S; McKeone D; Mulieri K
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1987. PubMed ID: 38351548
[TBL] [Abstract][Full Text] [Related]
4. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
[TBL] [Abstract][Full Text] [Related]
5. Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia.
Zhang M; Bostrom B
F1000Res; 2019; 8():176. PubMed ID: 30828444
[TBL] [Abstract][Full Text] [Related]
6. Acral Skin Rash Caused by Altered Mercaptopurine Metabolism in Maintenance Therapy for B-Cell Acute Lymphoblastic Leukemia.
Newcome J; Geib KB; Thompson P; Gold S; Alexander TB
J Pediatr Hematol Oncol; 2022 Oct; 44(7):398-401. PubMed ID: 35180762
[TBL] [Abstract][Full Text] [Related]
7. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
8. Severe mercaptopurine-induced hypoglycemia in acute lymphoblastic leukemia.
Rebelo A; Oliveira J; Sousa C
Pediatr Hematol Oncol; 2020 Apr; 37(3):245-247. PubMed ID: 31984843
[TBL] [Abstract][Full Text] [Related]
9. Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL).
Stuckert AJ; Schafer ES; Bernhardt MB; Baxter P; Brackett J
Leuk Lymphoma; 2020 May; 61(5):1246-1249. PubMed ID: 31842647
[No Abstract] [Full Text] [Related]
10. Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism.
Brackett J; Schafer ES; Leung DH; Bernhardt MB
Pediatr Blood Cancer; 2014 Jun; 61(6):1114-7. PubMed ID: 24376133
[TBL] [Abstract][Full Text] [Related]
11. A mathematical model of white blood cell dynamics during maintenance therapy of childhood acute lymphoblastic leukemia.
Le TTT; Jost F; Raupach T; Zierk J; Rauh M; Suttorp M; Stanulla M; Metzler M; Sager S
Math Med Biol; 2019 Dec; 36(4):471-488. PubMed ID: 30357334
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of methotrexate and 6-mercaptopurine dosage during maintenance chemotherapy for childhood acute lymphoblastic leukemia.
Schmiegelow K
Pediatr Hematol Oncol; 1991; 8(4):301-12. PubMed ID: 1782110
[TBL] [Abstract][Full Text] [Related]
13. [Progress of Research on 6-Thioguanine versus 6-Mercaptopurine in childhood ALL].
Hou YJ; Zhao L; Liu XX; Ma YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):622-6. PubMed ID: 27151041
[TBL] [Abstract][Full Text] [Related]
14. Sinusoidal Obstruction Syndrome During Maintenance Therapy for Acute Lymphoblastic Leukemia With 6-Mercaptopurine and Methotrexate: A Pediatric Case Report.
McNerney KO; Vasquez JC; Kent MW; McNamara JM
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e454-e455. PubMed ID: 28085749
[TBL] [Abstract][Full Text] [Related]
15. TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of tandem repeat-dependent manner.
Kotur N; Dokmanovic L; Janic D; Stankovic B; Krstovski N; Tosic N; Katsila T; Patrinos GP; Zukic B; Pavlovic S
Pharmacogenomics; 2015; 16(15):1701-12. PubMed ID: 26411491
[TBL] [Abstract][Full Text] [Related]
16. The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children.
Tanaka Y; Manabe A; Nakadate H; Kondoh K; Nakamura K; Koh K; Utano T; Kikuchi A; Komiyama T
Leuk Res; 2012 May; 36(5):560-4. PubMed ID: 22200619
[TBL] [Abstract][Full Text] [Related]
17. 6-Mercaptopurine cumulative dose: a critical factor of maintenance therapy in average risk childhood acute lymphoblastic leukemia.
Dibenedetto SP; Guardabasso V; Ragusa R; Di Cataldo A; Miraglia V; D'Amico S; Ippolito AM
Pediatr Hematol Oncol; 1994; 11(3):251-8. PubMed ID: 8060809
[TBL] [Abstract][Full Text] [Related]
18. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
[TBL] [Abstract][Full Text] [Related]
19. 6-mercaptopurine: efficacy and bone marrow toxicity in childhood acute lymphoblastic leukemia. Association with low (thio)purine enzyme activity.
De Abreu RA; Lambooy LH; Ahment K; Brouwer C; Keizer-Garritsen JJ; Bokkerink JP; Trijbels FJ
Adv Exp Med Biol; 2000; 486():271-5. PubMed ID: 11783498
[No Abstract] [Full Text] [Related]
20. 6-mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia.
Schmiegelow K; Bretton-Meyer U
Leukemia; 2001 Jan; 15(1):74-9. PubMed ID: 11243403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
